Ginkgo for memory enhancement: a randomized controlled trial
- PMID: 12186600
- DOI: 10.1001/jama.288.7.835
Ginkgo for memory enhancement: a randomized controlled trial
Abstract
Context: Several over-the-counter treatments are marketed as having the ability to improve memory, attention, and related cognitive functions in as little as 4 weeks. These claims, however, are generally not supported by well-controlled clinical studies.
Objective: To evaluate whether ginkgo, an over-the-counter agent marketed as enhancing memory, improves memory in elderly adults as measured by objective neuropsychological tests and subjective ratings.
Design: Six-week randomized, double-blind, placebo-controlled, parallel-group trial.
Setting and participants: Community-dwelling volunteer men (n = 98) and women (n = 132) older than 60 years with Mini-Mental State Examination scores greater than 26 and in generally good health were recruited by a US academic center via newspaper advertisements and enrolled over a 26-month period from July 1996 to September 1998.
Intervention: Participants were randomly assigned to receive ginkgo, 40 mg 3 times per day (n = 115), or matching placebo (n = 115).
Main outcome measures: Standardized neuropsychological tests of verbal and nonverbal learning and memory, attention and concentration, naming and expressive language, participant self-report on a memory questionnaire, and caregiver clinical global impression of change as completed by a companion.
Results: Two hundred three participants (88%) completed the protocol. Analysis of the modified intent-to-treat population (all 219 participants returning for evaluation) indicated that there were no significant differences between treatment groups on any outcome measure. Analysis of the fully evaluable population (the 203 who complied with treatment and returned for evaluation) also indicated no significant differences for any outcome measure.
Conclusions: The results of this 6-week study indicate that ginkgo did not facilitate performance on standard neuropsychological tests of learning, memory, attention, and concentration or naming and verbal fluency in elderly adults without cognitive impairment. The ginkgo group also did not differ from the control group in terms of self-reported memory function or global rating by spouses, friends, and relatives. These data suggest that when taken following the manufacturer's instructions, ginkgo provides no measurable benefit in memory or related cognitive function to adults with healthy cognitive function.
Comment in
-
Ginkgo and memory.JAMA. 2003 Feb 5;289(5):547; author reply 547-8. doi: 10.1001/jama.289.5.547-a. JAMA. 2003. PMID: 12578473 No abstract available.
-
Ginkgo and memory.JAMA. 2003 Feb 5;289(5):547; author reply 547-8. doi: 10.1001/jama.289.5.547-b. JAMA. 2003. PMID: 12578474 No abstract available.
-
Ginkgo and memory.JAMA. 2003 Feb 5;289(5):546-7; author reply 547-8. doi: 10.1001/jama.289.5.546-c. JAMA. 2003. PMID: 12578475 No abstract available.
-
Ginkgo and memory.JAMA. 2003 Feb 5;289(5):546; author reply 547-8. doi: 10.1001/jama.289.5.546-b. JAMA. 2003. PMID: 12578476 No abstract available.
-
Ginkgo and memory.JAMA. 2003 Feb 5;289(5):546; author reply 547-8. doi: 10.1001/jama.289.5.546-a. JAMA. 2003. PMID: 12578477 No abstract available.
Similar articles
-
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.Hum Psychopharmacol. 2002 Aug;17(6):267-77. doi: 10.1002/hup.412. Hum Psychopharmacol. 2002. PMID: 12404671 Clinical Trial.
-
An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.J Altern Complement Med. 2000 Jun;6(3):219-29. doi: 10.1089/acm.2000.6.219. J Altern Complement Med. 2000. PMID: 10890330 Clinical Trial.
-
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.JAMA. 2009 Dec 23;302(24):2663-70. doi: 10.1001/jama.2009.1913. JAMA. 2009. PMID: 20040554 Free PMC article. Clinical Trial.
-
Ginkgo biloba for cognitive impairment and dementia.Cochrane Database Syst Rev. 2002;(4):CD003120. doi: 10.1002/14651858.CD003120. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2007 Apr 18;(2):CD003120. doi: 10.1002/14651858.CD003120.pub2 PMID: 12519586 Updated. Review.
-
Ginkgo biloba: specificity of neuropsychological improvement--a selective review in search of differential effects.Hum Psychopharmacol. 2009 Jul;24(5):345-70. doi: 10.1002/hup.1037. Hum Psychopharmacol. 2009. PMID: 19551805 Review.
Cited by
-
A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment.Syst Rev. 2023 Aug 17;12(1):143. doi: 10.1186/s13643-023-02301-6. Syst Rev. 2023. PMID: 37592293 Free PMC article.
-
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy.Pharmaceutics. 2023 May 22;15(5):1562. doi: 10.3390/pharmaceutics15051562. Pharmaceutics. 2023. PMID: 37242804 Free PMC article. Review.
-
Dietary Flavonoids and Human Cognition: A Meta-Analysis.Mol Nutr Food Res. 2022 Nov;66(21):e2100976. doi: 10.1002/mnfr.202100976. Epub 2022 Apr 7. Mol Nutr Food Res. 2022. PMID: 35333451 Free PMC article.
-
Can We Use Ginkgo biloba Extract to Treat Alzheimer's Disease? Lessons from Preclinical and Clinical Studies.Cells. 2022 Jan 29;11(3):479. doi: 10.3390/cells11030479. Cells. 2022. PMID: 35159288 Free PMC article. Review.
-
The Effect of Polyphenols on Working and Episodic Memory in Non-pathological and Pathological Aging: A Systematic Review and Meta-Analysis.Front Nutr. 2022 Jan 26;8:720756. doi: 10.3389/fnut.2021.720756. eCollection 2021. Front Nutr. 2022. PMID: 35155509 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
